Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to study how helpful the combination of thalidomide and
Pamidronate or thalidomide and Zometa is in controlling the myeloma disease and to study any
side effects.